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ABSTRACT: Background. Swallowing dysfunction following
chemoradiation for head and neck cancer is a major cause of morbidity
and reduced quality of life. This review discusses 3 strategies that may
improve posttreatment swallowing function.
Methods. The literature was assessed by a multiauthor team that
produced evidence-based recommendations.
Results. (1) Prospective and randomized studies with small cohorts show
a trend toward benefits for a preventative exercise program addressing
oral and pharyngeal structures. (2) Prospective and retrospective data
indicate that better swallowing outcomes are likely when nasogastric
tubes are used in preference to gastrostomy tubes to supplement enteral
nutrition during chemoradiation. (3) Emerging prospective data with
mature results on small cohorts support the hypothesis that radiation dose
restriction to swallowing structures using intensity-modulated radiation
therapy techniques leads to better swallow outcomes.
Conclusions. This study discusses 3 strategies for improving swallow-
related outcomes in patients undergoing chemoradiation for head and
neck cancer and identifies areas for future research. VC 2013 Wiley
Periodicals, Inc. Head Neck 36: 431–443, 2014
KEY WORDS: dysphagia, chemoradiation, tube feeding, IMRT,
swallowing exercise
INTRODUCTION
Among the most profound effects of chemoradiation
(CRT) for head and neck cancer is the impact on the abil-
ity to eat and drink. It is recognized that organ-preserving
CRT regimes do not necessarily result in functional swal-
lowing preservation.1 Prospective studies have identified
swallowing function as a top priority for patients with
head and neck cancer both at diagnosis and after treat-
ment.2 Dysphagia can result in dehydration and malnutri-
tion and place people at risk of aspiration. Dysphagia is
one of the key factors that can reduce quality of life
(QOL), with increased severity of dysphagia correlating
with increased adverse effects on QOL anxiety and
depression.3 The use of CRT in the management of
advanced head and neck cancers, combined with a reduc-
tion of mean age at diagnosis for some of these tumors
make QOL and survivorship important considerations.
This review will identify if strategies exist in the current
literature to reduce dysphagia-related morbidity and
assess the strengths of the available evidence and make
recommendations for practice.
During treatment, almost all patients receiving CRT
need nutritional supplementation because the toxicity of
treatment is severe enough to impair adequate nutritional
intake.4 The treatment fields often are wide to encompass
a large area, including the salivary glands and swallowing
musculature. Some may avoid feeding tube placement
with aggressive swallowing therapy initiated at the begin-
ning of treatment, optimal analgesia, augmented nutrition
and intravenous fluids, supported by a multidisciplinary
team that includes speech and language therapists and
dietitians, also known as speech–language pathologists
and nutritionists in the United States.
This review will comprehensively evaluate the evidence
base pertaining to 3 strategies that have been shown on
exploratory studies to reduce long-term swallowing
morbidity. These include the use of prophylactic swallow-
ing exercises, avoiding gastrostomy tubes (G-tubes)
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during CRT and using intensity-modulated radiation ther-
apy (IMRT) techniques to reduce the dose delivered to
swallowing-related organs at risk.
The literature on evaluation of swallowing function is
hampered by the use of a variety of measures that are not
comparable. In addition, several authors present only
QOL data and interchangeably discuss these as functional
outcomes. Although QOL measurements are affected by
function, it must be noted that they do not necessarily
measure function, and care should be taken when reading
into the results. This report will summarize the published
data as presented with appropriate commentary, but
assumes that the reader is familiar with the various meas-
ures discussed.
Prophylactic swallowing exercises
Swallowing difficulties can occur as a result of acute
and late treatment effects.5 Acutely, patients may experi-
ence mucositis, edema, and erythema, compounded by
taste changes, nausea, and xerostomia. This has an impact
on the ability and desire to swallow, and disuse of the
skeletal muscles involved in swallowing during treatment
may cause weakness. The importance of continuing with
even limited oral intake during treatment has been high-
lighted in the literature.6
Radiation-induced fibrosis in the swallowing structures
can occur due to abnormal tissue healing following treat-
ment with hyperactivation of transforming growth factor
beta (TGF-b) and connective tissue growth factor
(CTGF). Fibrotic connective tissue wraps around muscle
fibers, resulting in restricted movement and, subsequently,
muscles fibers become weak due to disuse atrophy.6
Although some patients are able to resume eating and
drinking after acute treatment effects resolve, others con-
tinue to experience difficulties. Swallowing difficulties
can result from the gradual onset of fibrosis or sudden,
late-onset fibrosis in those who have historically managed
well following treatment.
The concept of exercises to reduce long-term swallow-
ing-related morbidity has been explored in several recent
studies. Early implementation of protective exercises has
been highlighted as an important intervention for patients
undergoing organ-preservation protocols for a number of
years, given the known impact of CRT on swallowing
function. However, it is only recently that studies have
started exploring the potential benefit of prophylactic
swallowing exercises for patients being treated with
radiotherapy. Despite the limited evidence base for pro-
phylactic swallowing exercises, the implementation of the
exercise programs has become an important component
of the management of patients undergoing organ-preser-
vation treatments. In the United Kingdom, 50% (n ¼ 21/
42) of speech and language therapist teams see patients
routinely prior to treatment with 71.4% (n ¼ 30/42) of
speech and language therapist teams recommending pro-
phylactic swallowing exercises.7 This compares with
18.3% of 759 individual speech and language therapists
in the United States.8 In the United States it was reported
by 70.6% of speech and language therapists that there is
no institutional policy for referrals or referrals are made
on a case-by-case basis.8 This difference may be
accounted for given that UK-based speech and language
therapists working in the National Health Service are
core members of the head and neck multidisciplinary
team as stated in national improving outcomes guidance.9
Therefore, they are invariably involved in patient care at
the outset.
To date there have been 6 studies published evaluating
prophylactic swallowing exercises and swallowing out-
comes including 3 randomized controlled trials (RCTs).
Despite the increased number of studies, a variety of
measures have been used to understand the potential
impact of prophylactic swallowing exercises on swallow-
ing (see Table 1). In each of the published studies, the
exercise prescriptions differ with exercise regimes initi-
ated at varying points, which are either unspecified, 2
weeks prior, or on the first day of treatment. Exercise
schedules also vary between studies and relied either on a
self-initiated exercise schedule or a program administered
under the direct supervision of a speech and language
therapist. Details of these exercise regimes are presented
in Table 1. The variety of reported regimes and exercise
prescriptions may explain the inconsistency in swallowing
therapy practice patterns reported in the United States
and the United Kingdom.7,8 In addition, a variety of out-
come measures have been reported with only 2 providing
baseline and posttreatment instrumental measures.10,11
Another important consideration is the difference in pro-
phylactic versus reactive tube feeding regimes between
centers (see Table 1) and how that might have an impact
on swallowing.
The first studies in this area were initiated at the same
center.12,13 Kulbersh et al12 studied 37 patients who
underwent primary radiation or combined CRT treatment
for newly diagnosed hypopharyngeal, laryngeal, or oro-
pharyngeal primary tumors. In this prospective cohort
analysis and cross-sectional QOL analysis, swallowing
exercises were taught to 25 patients 2 weeks prior to the
start of radiation. The MD Anderson Dysphagia Inventory
(MDADI)14 was administered an average of 14 months
after treatment to assess the success of the protocol.
Patients who performed pretreatment swallowing exer-
cises (n ¼ 25) showed improvement in the overall
MDADI score (p ¼ .0002) compared with the control
population (n ¼ 12) who underwent posttreatment ther-
apy. Furthermore, a separate analysis of individual
domains of the MDADI (global, emotional, functional,
and physical) demonstrated improved QOL.
In a retrospective case control study, Carroll et al13
compared patients who completed a prophylactic exercise
program (n ¼ 9) with those completing a posttreatment
regime (n ¼ 9). A videofluoroscopy (VFS) was carried
out 3 months after treatment. Significant differences in
epiglottic inversion (p ¼ .02) and tongue base position
during the swallow (p ¼ .025) were observed in the pro-
phylactic exercise group over the control group. The limi-
tation of this study is the lack of baseline swallowing
measures given the potential impact of cancer on pretreat-
ment swallowing function.15–17
A more recent, prospective nonrandomized study18 has
challenged the benefit of preventative swallowing rehabil-
itation. Ahlberg et al8 compared 190 patients receiving
preventive rehabilitation with 184 patients in the control
group on a range of measures detailed in Table 1. Despite
the admirable sample size, this heterogeneous group
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included patients who had undergone major surgery prior
to receiving radiotherapy with or without chemotherapy.
Brachytherapy was also used in certain cases. Although a
range of measures were comparable across groups, only
the experimental group underwent more detailed evalua-
tion, including a clinical swallowing evaluation. Speech
and language therapy measures were collected at baseline
and 3 months. Physiotherapy measures were collected at
2, 6, and 12 months after treatment completion. The pro-
ject-specific questionnaire focused on self-reported func-
tional losses and also contained questions about rehabili-
tation and working ability. Interestingly, patients in the
control group reported significantly less swallowing diffi-
culties than those in the study group, with a proportional
odds ratio (OR) of 2.3 (95% confidence interval [CI]:
1.3–4.0). In the control group, 58% answered that they
could swallow all consistencies of food compared with
35% in the study group (p < .001; data not shown in
tables). There was a significantly higher number of
patients using high energy/protein supplements in the
study group (60%) than in the control group (32%) (p <
.001). The authors discuss the possibility that patients in
the study group may have been more aware of swallow-
ing problems and nutritional issues and may have had
higher expectations regarding their functional status. The
total incidence of reported swallowing problems was 61%
(114/185). No parameters in the European Organisation
for Research and Treatment of Cancer (EORTC) ques-
tionnaire19 or the Hospital Anxiety Depression Scale
(HADS)20 showed any significant difference between the
2 groups at 6 months after termination of treatment.
van der Molen et al10 published the first RCT on 55
patients with various head and neck primaries undergoing
CRT to a standard or an experimental preventive rehabili-
tation arm (see Table 1). They specify that these patients
received IMRT. Complete posttreatment data were avail-
able for 49 patients. Structured multidimensional assess-
ment was performed before and 10 weeks after CRT (see
Table 1). This study did not include a "no intervention
group," given that Dutch national guidelines deem it
unethical to withhold rehabilitation. Only 4% (n ¼ 2) of
patients were tube fed prior to treatment and, although
this increased to 76% (n ¼ 38) by the end of radiother-
apy, by the 10-week point this had reduced to 37% (n ¼
18). Compared with similar CRT studies at the same
institution, fewer patients were still tube-dependent after
CRT. They concluded that exercises were helpful in
reducing the extent and/or severity of various functional
short-term effects of CRT. This group recently presented
their 2-year posttreatment results and found that no signif-
icant functional differences were found between the 2
preventative exercise groups.21 However, functional diffi-
culties were limited when compared with a previous trial
where exercises were not implemented.
Carnaby-Mann et al11 conducted an RCT comparing
the effectiveness of preventative behavioral intervention
for dysphagia. Patients were treated with conventional
radiotherapy or IMRT with or without chemotherapy.
Patients were randomized to 3 arms: usual care (UC),
sham exercises, and high intensity swallowing therapy
("pharyngocise"). The UC group were evaluated by the
radiation oncologist and received supervision for feeding
and safe swallowing precautions and received weekly
phone reviews from a research assistant. The sham group
carried out a buccal extension exercise and dietary modi-
fication as required. The latter was comprised of a battery
of exercises for the swallowing musculature (see Table
1). These included exercises such as tongue press, hard
swallow, and jaw resistance/strengthening using the Ther-
abite Jaw Motion Rehabilitation System. Both the sham
exercise and swallow exercise group performed repeti-
tions of their exercise schedule for 45 minutes, twice
daily for the duration of the treatment under the supervi-
sion of the study speech and language therapists.
A potential reduction in loss of muscle structure due to
prophylactic swallowing exercises has been noted inci-
dentally in the literature.13,22 This was addressed in the
study reported by Carnaby-Mann et al.,11 the primary out-
come measure being the change in size of the muscles of
the tongue and floor of mouth (mylohyoid, hyoglossus,
and genioglossus) and the pharyngeal constrictor muscles
on T2-weighted magnetic resonance imaging (MRI) scans
at 3 time points: before treatment, after treatment, and at
6 months after randomization. The results of this study
showed less structural loss in the genioglossus, hyoglos-
sus, and mylohyoid muscles in the group receiving high
intensity swallowing therapy; the study did not report the
results for the constrictor muscles due to movement arti-
fact. Patient outcome measures showed the functional
swallowing ability deteriorated less in the pharyngocise
group than in the UC, with this being statistically signifi-
cant (p  .03); there was no difference compared with
the sham exercises group (p < .06). They also reported
that MRI results for the sham group fell between the con-
trol and pharyngocise group. Given these data, the authors
suggest that there may be benefit to lower intensity exer-
cise programs. The Functional Oral Intake Scale (FOIS)
scores did not change significantly among the groups.
During treatment, it was found that patients in the phar-
yngocise group maintained oral feeding more often than
those in the UC group (42% vs 14%) and fewer required
gastrostomy feeding than the no intervention group (20%
vs 30%). The authors report that their data were most
complete at 6 weeks posttreatment as withdrawal rates at
6 months prevented meaningful analysis of the data.
An RCT was reported recently outlining a prophylactic
exercise program versus a UC approach in 26 patients
undergoing CRT.23 Swallowing function was evaluated
using the FOIS24 and Performance Status Scale for Head
and Neck Cancer (PSS-HN)25 at 3, 6, 9, and 12 months.
The intervention group completed exercises during treat-
ment (see Table 1) and a weekly therapy session was pro-
vided to improve program adherence and check tech-
nique. They found that 9 of the 13 patients in the
intervention group were able to complete their exercises
throughout treatment, although 4 of them ceased exercises
in week 4 and another 5 by week 5 of their treatment.
Patients ceased treatment due to pain and fatigue. Signifi-
cant differences were noted between groups with the
intervention group having improved FOIS and PSS-HN
Normalcy of Diet scores at 3 and 6 months but not in the
immediate posttreatment period or at 9 and 12 months.
Twelve patients required gastrostomy feeding, although
no statistical difference in placement between groups was
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reported and the median removal time was 3 months. The
authors recognize the limited sample size in this study
and the need for a larger number of patients for future
studies.
In these times of financial austerity, it is crucial that
work has been reported on the potential cost effectiveness
of rehabilitation programs in Europe and the United
States.26,27 Using the data from their RCT,10 researchers
at the Netherlands Cancer Institute have developed a
Markov decision model of a preventative exercise pro-
gram (PREP) versus UC.27 The UC data were acquired
from previous RCTs at their center comparing intra-arte-
rial and intravenous CRT.28,29 Although it was found that
PREP was more cost effective than UC, the authors high-
light that results are based on preliminary data and limita-
tions exist such as comparable disease subsites between
the groups and radiotherapy technique. Recently pre-
sented data from the United States also used a Markov
model to estimate the incremental cost-effectiveness ratio
of a prophylactic exercise program versus a posttreatment
program in 100 patients with hypothetical head and neck
cancer.26 They found that a preventative program of
swallowing exercises in patients receiving CRT was clini-
cally beneficial and led to significant cost savings over
usual, posttreatment care. It should be noted that accurate
assessment of cost effectiveness relies on good evidence
for the incremental benefit of a treatment because it is
not possible to accurately populate the transition probabil-
ities in a Markov model. However, these studies have
paved the way for others to evaluate the cost-effective-
ness of their rehabilitation interventions as more data
become available.
In each of these studies, the researchers have made a
significant contribution to our understanding of how pro-
phylactic swallowing exercises may influence the swal-
lowing outcome. This area of study is developing and,
given the limited evidence base, clinicians have adopted
what they feel to be the most appropriate intervention
based on published data and clinical experience.30 At this
stage, the results of these studies present the clinician
attempting to translate research findings into clinical
practice with a number of questions. When should
exercises start? Which exercises should patients do? How
frequently should they carry them out? How long should
patients continue exercises for? What are the long-term
benefits of prophylactic swallowing exercises?
Adherence to exercises and the support needed by
patients is a key issue to understand the true benefit and
feasibility of these programs. Three of the published stud-
ies reported how patient adherence was ascertained.10,11
The significant toxicity experienced during treatment may
have an impact on the individual’s ability to carry out
exercises. Pretreatment counseling by speech and lan-
guage therapists is crucial and patients should understand
the rationale and potential benefits of swallowing rehabil-
itation so that they become motivated rehabilitation part-
ners.30 Recently presented data from an RCT in the
United States have shown that improved outcomes can be
achieved in a therapist-assisted exercise program over
self-directed exercises.31 Furthermore, the presence of
depression and fatigue prior to starting prophylactic exer-
cises can influence adherence to programs.32 This further
supports the need for detailed, multidimensional evalua-
tion of patients’ pretreatment to improve swallowing
outcomes.
In the absence of multidimensional pretreatment evalu-
ation (including instrumental assessment), it is not possi-
ble to specify which exercises may be the most beneficial
for individuals. Further longitudinal studies with greater
numbers are required to understand the relative benefits
of strengthening and range of motion exercises on swal-
lowing outcome. In addition, there should be clarity on
the most effective exercise programs, including
dose–response data. Speech and language therapists rec-
ognize the importance of tailoring swallowing rehabilita-
tion to the individual (often impossible to do in a clinical
trial) both prior to and following treatment based on
information acquired through detailed swallowing evalua-
tion.7 In addition to exercise, it is important that the
effect of other treatments are explored such as lymphe-
dema therapy, massage, and stretching.33 Limitation of
significant variables such as excluding patients who have
undergone significant surgical resection is essential given
the swallowing difficulties that may result. To understand
the potential effects of prophylactic exercise regimes on
swallowing outcome, researchers should clearly document
the tube feeding approach at their center and whether
patients received conventional or IMRT. The implications
of these factors are discussed in the following sections.
Use of gastrostomy tubes
Prophylactic gastrostomy placement is associated with
several benefits to patients undergoing CRT. These
include a wider portal for nutritional supplementation that
is less prone to blockage and, from a patient perspective,
can be covered by clothing. On the contrary, nasogastric
(NG) tubes are beset by problems of easy blockage and
cannot be concealed. The indications, benefits, and draw-
backs of a pretreatment gastrostomy have been reviewed
in detail in the literature.34 It is reasonable to say that no
consensus exists on several key issues. However, this
review will focus on the issue of adverse effects, if any,
that gastrostomy use may have on the swallowing per-
formance after treatment.
Gastrostomy placement does reduce the need for the
patient undergoing CRT to swallow to maintain nutrition.
Thus, it is likely that patients using G-tubes exhibit a
reduction in use of the swallowing musculature. This
reduction in use of the swallowing musculature, com-
bined with the mucositis caused by radiation, has been
hypothesized to increase the risk of fibrosis in the
muscles and pharyngoesophageal stricture. Data from pro-
spective studies suggest that patients tend to retain G-
tubes longer than NG tubes.35–37 On this basis, some cen-
ters have moved away from prophylactic G-tubes, with
the assumption that patients avoid oral intake earlier, if
an alternative feeding route is available.
Four retrospective studies,38–40 one prospective study,36
and one randomized trial35 have explored this hypothesis.
Mekhail et al38 retrospectively compared 29 NG-fed
patients with 62 G-tube fed patients, finding that G-tube
fed patients had more dysphagia at 3 months (59% vs
30%; p ¼ .015) and at 6 months (30% vs 8%; p ¼ .029).
The median tube retention duration was also higher for
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the G-tube group. However, this study used a gross dys-
phagia grading system, with limited long-term follow-up,
so the impact on swallowing impairment and tube selec-
tion remains unknown. There may be other "unknown"
patient factors that are difficult to capture such as levels
of determination and prioritization attributed to eating,
affecting tube duration. In this study, 19 G-tube–fed
patients have been shown to require pharyngoesophageal
dilatation more frequently compared with NG-tube–fed
patients (23% vs 4%; p ¼ .022).
Oozeer et al39 retrospectively compared patient-reported
swallowing outcomes, using the MDADI, between 2
groups treated by primary CRT: 1 group received nutri-
tional supplementation via a prophylactic G-tube and the
other by the oral route or as required via a NG tube. The
groups were matched for age, site, and stage of tumor
and were disease-free at least 24 months following treat-
ment. The prophylactic gastrostomy group consisted of 16
patients and the oral/NG tube group of 15 patients. There
were statistically significant differences in MDADI scores
between the 2 groups in all domains of the questionnaire
(p < .001), with superior outcomes in the NG group.
They concluded that use of G-tubes during CRT con-
ferred a worse swallowing outcome in the long term in
this tightly matched cohort of patients.
Chen et al40 retrospectively studied 120 consecutive
patients treated with CRT for Stage III/IV head and neck
cancer, with the most common primary site in the cohort
being the oropharynx (66 patients). Sixty-seven patients
(56%) were treated using IMRT. Seventy patients (58%)
received prophylactic gastrostomy placement. They found
that prophylactic gastrostomy placement reduced mean
weight loss during radiation therapy from 43 pounds
(range, 0–76 pounds) to 19 pounds (range, 0–51 pounds),
and this reduction was statistically significant (p < .001).
However, the proportion of patients who were gastros-
tomy dependent at 6 and 12 months after treatment was
higher for those who received prophylactic G-tube (41%
and 21%, respectively), compared with those who did not
receive prophylactic G-tube (8% and 0%, respectively);
this difference was statistically significant (p < .001).
Additionally, prophylactic G-tube was associated with a
significantly higher incidence of late esophageal stricture
compared with those who did not have prophylactic G-
tube (30% vs 6%, p < .001).
The above studies, although retrospective, show clear
trends for better swallowing in those who do not receive
prophylactic gastrostomy. It is feasible that the presence
of a NG tube or continued oral swallowing uses the
muscles of swallowing more frequently, leading to reduc-
tion in muscle fibrosis and thus a better swallowing
outcome.
There are 2 prospective studies on the subject of tube
feeding and swallowing outcomes. In a prospective study
comparing swallowing outcomes using the Common Tox-
icity Criteria, version 2.0 (CTC v2.0) dysphagia grade in
32 G-tube fed patients and 73 NG-fed patients, Corry et
al36 found that there was more grade 3 dysphagia in G-
tube fed disease-free survivors at 6 months (25% vs 8%,
p ¼ .07). These authors preceded this prospective cohort
with a RCT that was terminated due to poor recruitment.
In the randomized trial,35 18 received an NG tube and 15
a G-tube. This study found no statistically significant dif-
ference in the rates of CTC v2.0 grade 3 dysphagia at 6
months post-RT (ie, ongoing use of feeding tube). There
were 4 of 15 patients in the G-tube group with grade 3
dysphagia compared with only 1 of 18 in the NG-tube
group (p ¼ .15).
One potential benefit of NG tubes is a reduction in
post-cricoid stricture formation, due to the tube acting as
a stent. Complete obliteration of the lumen has been
reported with G-tube use, but never with NG tubes.38,40,41
There is no doubt that patients with head and neck can-
cer may present with swallowing difficulties due to their
cancer at diagnosis.16,17 They may be at risk of aspiration
and its sequelae and nutritional compromise and may
require placement of a feeding tube prior to treatment.
Other patients may not have any dysphagia and specialist
multidisciplinary support during treatment including opti-
mal symptom control, swallowing rehabilitation, and
nutritional advice are crucial. Appropriate selection of
patients who may require tube feeding is crucial and
should be based on best evidence, detailed speech and
language therapist and dietetic evaluation, and patient
preference in a multidisciplinary setting. Avoiding or
reducing prophylactic gastrostomy use may not be possi-
ble in several clinical scenarios. Examples include
patients with significant pretreatment dysphagia, those
anticipated to require >8 weeks enteral nutrition, and/or
with very advanced (usually T4) primary tumors, espe-
cially in the hypopharynx. A recent study has found that
even if tube feeding is implemented, patients who contin-
ued with even limited oral intake maintained significantly
improved swallowing function over those who relied
exclusively on tube feeding.6 Another important consider-
ation is the fact that many head and neck cancer patients
eat despite evidence of dysphagia or aspiration on instru-
mental evaluation. Therefore dysphagia burden may be
underestimated if judged solely on the basis of the pres-
ence of gastrostomy.42
IMRT as a strategy to reduce swallowing dysfunction
The rationale for using the IMRT technique as a strat-
egy to avoid dysphagia is based on the established rela-
tionship between functional status of the swallowing-
related structures and the pattern of irradiation dose distri-
bution in these structures and on the ability of the IMRT
to shape the high-dose volume in accord with the 3-
dimensional outline of the target(s). This way, nearby
structures not infiltrated with cancer cells are irradiated
with lower doses, which allow at least partial preservation
of their function. Recently reported results of the PAR-
SPORT study, a RCT that found parotid-sparing IMRT a
valuable method for reducing the incidence of severe
xerostomia, can be considered as a proof of principle.43
The pioneering work of Eisbruch et al44 recognized that
muscular components of the swallowing apparatus, criti-
cal to the development of dysphagia in irradiated patients,
can be spared by IMRT. Studies have found significant
correlation with dysphagia/aspiration and various dose–
volume parameters for the pharyngeal constrictor muscles
(superior, medial, and inferior group), esophageal inlet,
and glottic and supraglottic larynx.45–48 Other authors
have confirmed these findings, with steep dose–response
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relationships between dose to different parts of swallow-
ing apparatus and dysphagia in the short to medium term
(Table 2). For instance, Levendag et al49 found a 19%
increase in the probability of late dysphagia grade 3/4
(>3 months after completion of the therapy) with every
additional 10 Gy after a dose of 55 Gy in superior con-
strictor muscles, whereas Caudell et al50 reported a 7% to
11% increase in risk for gastrostomy dependence or aspi-
ration with every 1-Gy increase in a mean dose to the lar-
ynx or inferior constrictor. Recently, van der Laan et al51
compared in their planning study 30 standard IMRT treat-
ment plans with swallowing-sparing IMRT plans that
aimed to reduce the dose to organs at risk for swallowing
dysfunction in the same patients. The dose characteristics
of the target volumes and normal structures, including pa-
rotid glands, were not allowed to differ between the 2
planning techniques. Adequate coverage of target vol-
umes and dose to critical structures within acceptable
limits were achieved, whereas the mean doses to the vari-
ous swallowing-related structures were reduced, depend-
ing on N classification and primary tumor location. In
addition, the observed dose reductions were reflected in
reduced estimates of the normal tissue complication prob-
ability values for both, physician-rated [Radiation Ther-
apy Oncology Group (RTOG) grade 3/4, for 9%] and
patient-rated measures for swallowing dysfunction (mod-
erate to severe complaints: for solid food 7.9%, for soft
food 2.4%, for liquid food 1.4%, for choking when swal-
lowing 0.9%). However, it must be noted that this
"threshold" may depend entirely on the outcome measure
chosen. For instance, Eisbruch et al52 correlated doses
with various outcome measures (objective and subjective
outcomes) and noted varying correlation of the doses
with each outcome measure. It is likely that mean pha-
ryngeal constrictor doses above 45–60 Gy are associated
with worse dysphagia.
Technical considerations
In line with the described importance of the
dose–volume relationships found for structures involved
in swallowing, the emerging role of IMRT planning has
been underlined by several authors. Whereas a significant
improvement in swallowing outcome between nonconfor-
mal 3-field technique and conformal "horseshoe" tech-
nique was described by Frowen et al,53 additional sparing
of swallowing structures can be achieved with IMRT and
its variants. Better sparing of the lower part of swallow-
ing apparatus, in particular the larynx, inferior pharyngeal
constrictor muscle, and esophageal inlet, was demon-
strated by using split-field IMRT technique. In this tech-
nique, an anterior low-neck field with a 2 cm midline
shielding block to protect larynx is matched with IMRT
fields covering primary tumor and upper parts of the
neck. Of note, compromised coverage of inferior parts of
elective nodal volumes had to be acknowledged even af-
ter modification of the technique (eg, by dynamic field
matching technique), which could be of particular impor-
tance in patients with extensive nodal disease and/or low-
sited primaries.54–57
However, whole-field IMRT can also offer an advant-
age of sparing organs at risk for swallowing dysfunction.
Eisbruch et al44 compared V50 (volume that received
50 Gy of irradiation) of the previously identified dys-
phagia/aspiration-related structures (pharyngeal constric-
tor muscles, surpraglottic and glottic larynx) on the stand-
ard 3-dimensional conformal radiotherapy (3D-CRT)
plan, standard IMRT plan, and dysphagia-optimized
IMRT plan (with sparing of these organs included in the
optimization process). All 3 plans were produced for each
of 20 patients included in the study. Compared with the
3D-CRT and standard IMRT, dysphagia-optimized IMRT
reduced V50 of the critical structures without compromis-
ing doses to the targets: in pharyngeal constrictors by
20% and 10% on average, respectively, and in the larynx
by 18% and 7%, respectively.
Furthermore, robust computed tomography (CT)-based
guidelines for delineations of the most relevant swallow-
ing organs at risk for irradiation-induced dysfunction
have since been published to facilitate objective compari-
son and interpretation of radiotherapy sequelae between
studies.58
Drawbacks of IMRT
There are some disadvantages associated with IMRT,
including a more inhomogeneous dose distribution, an
increased risk of a marginal miss, increased total body
dose, and increased time and expense.59,60 One of the
problems associated with radiotherapy, including IMRT,
is the "Jello effect," where reducing the dose to one adja-
cent normal tissue structure simply pushes dose toward
another. Another problem is that the swallowing muscula-
ture may be close to the primary and reducing the dose
to these structures might increase the risk of a marginal
recurrence.
A recent review of 26 studies (10 used IMRT and 16
used conventional techniques) with 4727 patients con-
cluded that IMRT studies reported a 3.3 fold increased risk
of pharyngoesophageal stricture compared with that of
conventional RT studies (OR: 3.3; 95% CI: 2.6–4.2; p <
.001). The study authors identify in the discussion that this
could be due to higher dose received by the larynx, infe-
rior constrictors, and cervical esophagus when whole-field
IMRT is used to irradiate the low neck. Unlike conven-
tional RT or split-field IMRT, whole-field IMRT does not
use a midline block to protect the larynx, inferior constric-
tors, and the cervical esophagus, resulting in higher doses
to these organs, unless they are specified as organs at risk
and an effort is made to spare them in the optimization
process. The authors accept that other confounding varia-
bles, such as taxanes, have been used in the IMRT studies
and thus results should be interpreted with caution.61
Finally, because the use of IMRT and concomitant
chemotherapy has increased, so has the use of percutane-
ous gastrostomy, which likely increases the risk of long-
term swallowing problems.34
Results of studies on IMRT and swallowing
A systematic review of the literature on swallowing
outcomes after IMRT by Roe et al7 (published in English
between 1998 and 2009) identified 16 papers that met
required inclusion criteria regarding methodologic quality
and method of swallowing assessment. They concluded
that a favorable swallowing outcome might be possible if
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radiation dose to certain structures is limited. Table 2
summarizes the literature to date with the addition of
more studies. The table includes data on the study design,
the outcome measures, swallowing outcome after treat-
ment, and pertinent comments from the current authors. It
is evident that it is impossible to compare results across
studies. This is due to heterogeneity in the patient popula-
tion, use of a range of outcome measures that have not
been shown to correlate with each other and limited use
of instrumental assessment (ie, Fiber-optic Endoscopic
Evaluation of Swallowing [FEES] and VFS). In addition,
the methods used to delineate and reduce dose to swal-
lowing organs at risk are not uniform.
As can be seen, this review has identified only 4 pro-
spective studies that have used a range of outcome meas-
ures to analyze the issue and are worthy of discussion.
The outcomes from the retrospective studies are summar-
ized in Table 2.
Prospective studies
The most robust evidence for the use of dose restriction
to swallowing organs at risk comes from the data pub-
lished by Eisbruch et al.52 In a cohort of 73 patients with
oropharyngeal cancer, followed up for up to 2 years, the
study identified that increasing radiation dose the pharyn-
geal constrictors and supraglottic larynx correlated with
worse function as measured using a variety of swallow-
ing-related outcome measures (objective and subjective).
As expected, the toxicity causing dose varied based on
the outcome measure. Similar results are seen in other
publications from the same center, albeit with shorter fol-
low-up times.62
Schwartz et al57 presented similar data on a smaller
cohort of 31 patients with oropharyngeal cancer enrolled
in a prospective phase II trial evaluating swallowing func-
tion at baseline, 6, 12, and 24 months post-IMRT. The
mean dose to the glottic larynx using an anterior field
with a midline block to shield the larynx was 18 Gy
(range, 6–39 Gy). Thirteen patients (42%) received con-
comitant chemotherapy. Swallowing structures were con-
toured and the doses to these structures were calculated.
One patient (3%) was feeding-tube dependent at 24
months. Using the MDADI and the Oropharyngeal Swal-
lowing Efficiency (OPSE) as outcome measures, this
study performed dose–volume analyses to identify candi-
date dysphagia-associated organs at risk. Although the
MDADI had no correlation to organ-at-risk doses, the
results demonstrated that reduction of dose to the anterior
oral cavity and high pharyngeal musculature resulted in
better OPSE outcomes.
Two studies have analyzed prospectively collected data
for other purposes.45,63 Despite the use of robust outcome
measures, the cross-sectional analysis and the conven-
ience sample reduced confidence in the results of these
studies. Other prospective studies recruit nonhomogene-
ous patient groups and assessing acute toxicity alone or
evaluate patients in the early posttreatment period.64,65
Recently, Christianen et al66 developed predictive mod-
els for different swallowing problems observed in patients
after curative (chemo)radiation, considering the most im-
portant dose–volume parameters and other pretreatment
factors that determine physician-rated and patient-rated
swallowing impairment. The study was prospectively
designed and included 354 patients with head and neck
cancer treated with (chemo)radiotherapy. The study found
different predictive models for specific swallowing prob-
lems; for instance, problems with swallowing liquids
were predicted best by dose to the supraglottic larynx,
whereas problems with solid food were predicted best by
the dose to the superior pharyngeal constrictor. Based on
the results, the authors hypothesize that for greater food
consistencies, the dose received by more cranial structures
was predictive because greater pressure needs to be built
to push the bolus down, and this head of pressure is gen-
erated more cranially. In routine clinical practice, how-
ever, the discussion on the importance of different dos-
e–volume parameters and swallowing structures in
determining dysphagia can be summarized as proposed by
Eisbruch et al52: the most critical structure depends on
location of the target(s). For superiorly sited tumors (eg,
oropharyngeal cancer) the most significant predictor of
swallowing disorders is the dose to the superior constrictor
muscle because this structure receives the highest doses,
whereas in patients with laryngeal cancer, the larynx and
inferior pharyngeal constrictors are at highest risk.
It is evident from the data presented in the table that 2
recent studies52,57 have avoided some of the methodologic
shortcomings and identify IMRT as a valid strategy to
reduce long-term dysphagia. If some of the ongoing trials
on deescalating therapy for human papillomavirus–posi-
tive disease show good oncologic efficacy with less inten-
sive treatment, the morbidity of posttreatment dysphagia
could be reduced even further.
Commentary on outcome measures
This review has highlighted the use of outcome meas-
ures to assess swallowing function that we feel are not fit
for that purpose. Measures such as gastrostomy retention
rate and pharyngoesophageal stricture, especially when
looked at on their own, are not robust. Several competing
factors can be responsible for patients retaining their G-
tubes. The interpretation of the presence of a stricture is
variable on a contrast swallow or on rigid esophageal dil-
atation. Furthermore, a mild stricture may not necessarily
be symptomatic for all patients. In the presence of several
robust patient reported outcome measures, we believe that
these should form an integral part of the outcomes
assessment.
CONCLUSIONS
Although 5 of 6 studies have demonstrated that prophy-
lactic swallowing exercises show benefit, further longitu-
dinal studies are required to evaluate the clinical and cost
benefit of prophylactic swallowing exercises and influenc-
ing factors. This will enable services to ensure optimal
timing for swallowing intervention and direction of valua-
ble resources.
It is likely that swallowing problems following radio-
therapy increase with the addition of concomitant chemo-
therapy and with increased radiation dose to various
structures that are part of the swallowing mechanism. The
majority of studies published so far indicate that reducing
the radiation dose to the larynx, pharyngeal constrictors,
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and cervical esophagus using IMRT appears to reduce the
risk of swallowing dysfunction while minimizing the risk
of a marginal miss so long as these structures are not part
of the planned target volume. Additionally, the use of a
G-tube may increase the probability of swallowing dys-
function. If adequate facilities are available for NG tube
care and support during CRT, these should be avoided
whenever possible. Rather than a one-size-fits-all
approach to tube placement, a multidisciplinary evalua-
tion based on each individual case is essential. This
ensures that those who need early tube feeding are identi-
fied and receive appropriate support to optimize swallow-
ing outcomes. Those not being tube fed at the outset
should receive expert dietetic and swallowing intervention
throughout treatment to ensure that their nutritional and
hydration needs are met safely. Supportive care provision
during treatment varies between centers7 and improved
swallowing outcomes rely on multidisciplinary interven-
tion, including psychological care and optimal
analgesia.67
Undoubtedly, all of the 3 strategies discussed here are
resource intensive. Given the findings of this review, we
believe that there is a clear trend for better swallow out-
comes to be experienced. Clearly, more prospective stud-
ies from several settings, taking into account the draw-
backs of the studies published so far, need to be
performed analyzing each of the 3 strategies discussed
here to generate more confidence in the results reported
earlier.
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